View ValuationMothercare 将来の成長Future 基準チェック /16Mothercareは、33%と11.8%でそれぞれ年率33%で利益と収益が成長すると予測される一方、EPSはgrowで33.6%年率。主要情報33.0%収益成長率33.57%EPS成長率Specialty Retail 収益成長13.5%収益成長率11.8%将来の株主資本利益率n/aアナリストカバレッジLow最終更新日14 Aug 2026今後の成長に関する最新情報Major Estimate Revision • Dec 30Consensus revenue estimates decrease by 42%The consensus outlook for fiscal year 2026 has been updated. 2026 revenue forecast fell from UK£45.9m to UK£26.8m. EPS estimate unchanged from -UK£0.0025 per share at last update. Specialty Retail industry in the United Kingdom expected to see average net income growth of 37% next year. Consensus price target down from UK£0.098 to UK£0.072. Share price rose 15% to UK£0.025 over the past week.Price Target Changed • Oct 18Price target decreased by 17% to UK£0.11Down from UK£0.13, the current price target is an average from 2 analysts. New target price is 115% above last closing price of UK£0.05. Stock is up 29% over the past year. The company is forecast to post earnings per share of UK£0.0049 next year compared to a net loss per share of UK£0.00018 last year.Price Target Changed • Oct 18Price target decreased by 17% to UK£0.11Down from UK£0.13, the current price target is an average from 2 analysts. New target price is 115% above last closing price of UK£0.05. Stock is up 29% over the past year. The company is forecast to post earnings per share of UK£0.0049 next year compared to a net loss per share of UK£0.00018 last year.Price Target Changed • Apr 19Price target increased by 15% to UK£0.15Up from UK£0.13, the current price target is provided by 1 analyst. New target price is 180% above last closing price of UK£0.053. Stock is down 39% over the past year. The company is forecast to post earnings per share of UK£0.005 next year compared to a net loss per share of UK£0.00018 last year.Price Target Changed • Mar 12Price target decreased by 15% to UK£0.14Down from UK£0.17, the current price target is an average from 2 analysts. New target price is 63% above last closing price of UK£0.086. Stock is down 30% over the past year. The company is forecast to post earnings per share of UK£0.0015 for next year compared to UK£0.021 last year.すべての更新を表示Recent updatesReported Earnings • Aug 16Full year 2026 earnings released: UK£0.009 loss per share (vs UK£0.011 profit in FY 2025)Full year 2026 results: UK£0.009 loss per share (down from UK£0.011 profit in FY 2025). Revenue: UK£22.4m (down 42% from FY 2025). Net loss: UK£5.00m (down 181% from profit in FY 2025). Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 2.6% growth forecast for the Specialty Retail industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has fallen by 49% per year, which means it is significantly lagging earnings.New Risk • Jul 12New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Share price has been highly volatile over the past 3 months (34% average weekly change). Negative equity (-UK£10m). Earnings are forecast to decline by an average of 72% per year for the foreseeable future. Market cap is less than US$10m (UK£3.95m market cap, or US$5.29m). Minor Risk Latest financial reports are more than 6 months old (reported September 2025 fiscal period end).New Risk • Apr 14New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 91% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Share price has been highly volatile over the past 3 months (18% average weekly change). Negative equity (-UK£10m). Earnings are forecast to decline by an average of 91% per year for the foreseeable future. Market cap is less than US$10m (UK£6.29m market cap, or US$8.52m).New Risk • Mar 23New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: UK£7.02m (US$9.43m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Share price has been highly volatile over the past 3 months (12% average weekly change). Negative equity (-UK£10m). Earnings are forecast to decline by an average of 95% per year for the foreseeable future. Market cap is less than US$10m (UK£7.02m market cap, or US$9.43m).New Risk • Mar 01New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of British stocks, typically moving 11% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Share price has been highly volatile over the past 3 months (11% average weekly change). Negative equity (-UK£10m). Earnings are forecast to decline by an average of 95% per year for the foreseeable future. Minor Risk Market cap is less than US$100m (UK£11.0m market cap, or US$14.8m).分析記事 • Jan 15Some Confidence Is Lacking In Mothercare plc's (LON:MTC) P/SIt's not a stretch to say that Mothercare plc's ( LON:MTC ) price-to-sales (or "P/S") ratio of 0.4x seems quite...New Risk • Jan 14New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of British stocks, typically moving 11% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Share price has been highly volatile over the past 3 months (11% average weekly change). Negative equity (-UK£10m). Earnings are forecast to decline by an average of 85% per year for the foreseeable future. Minor Risk Market cap is less than US$100m (UK£11.3m market cap, or US$15.2m).Major Estimate Revision • Dec 30Consensus revenue estimates decrease by 42%The consensus outlook for fiscal year 2026 has been updated. 2026 revenue forecast fell from UK£45.9m to UK£26.8m. EPS estimate unchanged from -UK£0.0025 per share at last update. Specialty Retail industry in the United Kingdom expected to see average net income growth of 37% next year. Consensus price target down from UK£0.098 to UK£0.072. Share price rose 15% to UK£0.025 over the past week.Reported Earnings • Dec 25First half 2026 earnings released: UK£0.003 loss per share (vs UK£0.003 loss in 1H 2025)First half 2026 results: UK£0.003 loss per share (in line with 1H 2025). Revenue: UK£11.6m (down 45% from 1H 2025). Net loss: UK£1.70m (loss narrowed 5.6% from 1H 2025). Revenue is forecast to grow 1.1% p.a. on average during the next 3 years, compared to a 3.5% growth forecast for the Specialty Retail industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has fallen by 33% per year, which means it is significantly lagging earnings.お知らせ • Sep 26Mothercare plc, Annual General Meeting, Nov 12, 2025Mothercare plc, Annual General Meeting, Nov 12, 2025. Location: westside 1, london road, hp3 9td, hemel hempstead United KingdomReported Earnings • Sep 25Full year 2025 earnings released: EPS: UK£0.011 (vs UK£0.006 in FY 2024)Full year 2025 results: EPS: UK£0.011 (up from UK£0.006 in FY 2024). Revenue: UK£38.9m (down 31% from FY 2024). Net income: UK£6.20m (up 88% from FY 2024). Profit margin: 16% (up from 5.9% in FY 2024). The increase in margin was driven by lower expenses. Revenue is forecast to grow 9.2% p.a. on average during the next 3 years, compared to a 3.8% growth forecast for the Specialty Retail industry in the United Kingdom. Over the last 3 years on average, earnings per share has fallen by 57% per year but the company’s share price has only fallen by 31% per year, which means it has not declined as severely as earnings.New Risk • Jun 25New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 16% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Negative equity (-UK£29m). Earnings are forecast to decline by an average of 16% per year for the foreseeable future. Minor Risks Latest financial reports are more than 6 months old (reported September 2024 fiscal period end). Share price has been volatile over the past 3 months (11% average weekly change). Market cap is less than US$100m (UK£16.2m market cap, or US$22.0m).New Risk • Jun 20New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Negative equity (-UK£29m). Earnings are forecast to decline by an average of 16% per year for the foreseeable future. Minor Risks Latest financial reports are more than 6 months old (reported September 2024 fiscal period end). Share price has been volatile over the past 3 months (11% average weekly change). Market cap is less than US$100m (UK£14.7m market cap, or US$19.8m).New Risk • May 12New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 16% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Negative equity (-UK£29m). Earnings are forecast to decline by an average of 16% per year for the foreseeable future. Minor Risk Market cap is less than US$100m (UK£12.6m market cap, or US$16.6m).分析記事 • May 09Take Care Before Jumping Onto Mothercare plc (LON:MTC) Even Though It's 26% CheaperUnfortunately for some shareholders, the Mothercare plc ( LON:MTC ) share price has dived 26% in the last thirty days...分析記事 • Mar 06Not Many Are Piling Into Mothercare plc (LON:MTC) Stock Yet As It Plummets 28%The Mothercare plc ( LON:MTC ) share price has fared very poorly over the last month, falling by a substantial 28%. For...分析記事 • Jan 12Market Might Still Lack Some Conviction On Mothercare plc (LON:MTC) Even After 27% Share Price BoostMothercare plc ( LON:MTC ) shares have had a really impressive month, gaining 27% after a shaky period beforehand. Not...Recent Insider Transactions • Dec 20Non-Executive Chairman recently bought UK£100k worth of stockOn the 18th of December, Clive Whiley bought around 4m shares on-market at roughly UK£0.025 per share. This transaction increased Clive's direct individual holding by 1x at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Clive's only on-market trade for the last 12 months.お知らせ • Nov 22Mothercare plc Announces Resignation of Mark Newton from the BoardMothercare plc announced upon Clive Whiley’s appointment as Chairman, Mark Newton Jones agreed to return to the board as a non-executive director to lend his support to the Transformation Plan and subsequently the actions necessary to combat the impact of the pandemic and the Ukraine conflict on the business. Accordingly, following creation of the new India joint venture and coterminous refinancing, Mark had indicated his intention to stand down from the board at its AGM and has now resigned as a director.お知らせ • Oct 22Mothercare plc, Annual General Meeting, Nov 19, 2024Mothercare plc, Annual General Meeting, Nov 19, 2024. Location: westside 1, london road, hp3 9td, hemel hempstead United Kingdom分析記事 • Oct 20Mothercare plc's (LON:MTC) Shares Climb 49% But Its Business Is Yet to Catch UpMothercare plc ( LON:MTC ) shares have had a really impressive month, gaining 49% after a shaky period beforehand...Reported Earnings • Oct 19First half 2024 earnings released: EPS: UK£0.003 (vs UK£0.001 in 1H 2023)First half 2024 results: EPS: UK£0.003 (up from UK£0.001 in 1H 2023). Revenue: UK£29.0m (down 25% from 1H 2023). Net income: UK£1.70m (up 325% from 1H 2023). Profit margin: 5.9% (up from 1.0% in 1H 2023). The increase in margin was driven by lower expenses. Revenue is expected to decline by 5.6% p.a. on average during the next 4 years, while revenues in the Specialty Retail industry in the United Kingdom are expected to grow by 5.4%.Price Target Changed • Oct 18Price target decreased by 17% to UK£0.11Down from UK£0.13, the current price target is an average from 2 analysts. New target price is 115% above last closing price of UK£0.05. Stock is up 29% over the past year. The company is forecast to post earnings per share of UK£0.0049 next year compared to a net loss per share of UK£0.00018 last year.Price Target Changed • Oct 18Price target decreased by 17% to UK£0.11Down from UK£0.13, the current price target is an average from 2 analysts. New target price is 115% above last closing price of UK£0.05. Stock is up 29% over the past year. The company is forecast to post earnings per share of UK£0.0049 next year compared to a net loss per share of UK£0.00018 last year.New Risk • Sep 21New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of British stocks, typically moving 9.7% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.9x net interest cover). Share price has been highly volatile over the past 3 months (9.7% average weekly change). Negative equity (-UK£13m). High level of non-cash earnings (23% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported September 2023 fiscal period end). Profit margins are more than 30% lower than last year (1.9% net profit margin). Market cap is less than US$100m (UK£18.9m market cap, or US$25.2m).分析記事 • Jul 04Is Mothercare plc (LON:MTC) Potentially Undervalued?Mothercare plc ( LON:MTC ), might not be a large cap stock, but it saw a decent share price growth of 13% on the AIM...New Risk • Jun 11New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.9x net interest cover). Negative equity (-UK£13m). High level of non-cash earnings (23% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported September 2023 fiscal period end). Share price has been volatile over the past 3 months (10% average weekly change). Profit margins are more than 30% lower than last year (1.9% net profit margin). Market cap is less than US$100m (UK£26.2m market cap, or US$33.4m).Price Target Changed • Apr 19Price target increased by 15% to UK£0.15Up from UK£0.13, the current price target is provided by 1 analyst. New target price is 180% above last closing price of UK£0.053. Stock is down 39% over the past year. The company is forecast to post earnings per share of UK£0.005 next year compared to a net loss per share of UK£0.00018 last year.分析記事 • Apr 18Mothercare plc (LON:MTC) Shares May Have Slumped 25% But Getting In Cheap Is Still UnlikelyMothercare plc ( LON:MTC ) shareholders that were waiting for something to happen have been dealt a blow with a 25...分析記事 • Jan 03Is Now The Time To Look At Buying Mothercare plc (LON:MTC)?Mothercare plc ( LON:MTC ), is not the largest company out there, but it led the AIM gainers with a relatively large...Reported Earnings • Nov 28First half 2024 earnings released: EPS: UK£0.003 (vs UK£0.001 in 1H 2023)First half 2024 results: EPS: UK£0.003 (up from UK£0.001 in 1H 2023). Revenue: UK£29.0m (down 25% from 1H 2023). Net income: UK£1.70m (up 325% from 1H 2023). Profit margin: 5.9% (up from 1.0% in 1H 2023). The increase in margin was driven by lower expenses. Revenue is forecast to grow 2.2% p.a. on average during the next 3 years, compared to a 5.5% growth forecast for the Specialty Retail industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 110% per year but the company’s share price has fallen by 23% per year, which means it is significantly lagging earnings.New Risk • Nov 26New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 2.3x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.3x net interest cover). Negative equity (-UK£13m). High level of non-cash earnings (23% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (10.0% average weekly change). Profit margins are more than 30% lower than last year (1.9% net profit margin). Market cap is less than US$100m (UK£29.9m market cap, or US$37.7m).分析記事 • Nov 04Mothercare plc (LON:MTC) Investors Are Less Pessimistic Than ExpectedWith a median price-to-sales (or "P/S") ratio of close to 0.3x in the Specialty Retail industry in the United Kingdom...お知らせ • Sep 27Mothercare plc, Annual General Meeting, Oct 23, 2023Mothercare plc, Annual General Meeting, Oct 23, 2023, at 10:00 Coordinated Universal Time. Location: Westside 1, London Road Hemel Hemsptead United Kingdom Agenda: To receive the Company's annual accounts, together with the directors' report, the strategic report, the directors' remuneration report and the auditors' report for the 52 weeks ended 25 March 2023; to approve the directors' remuneration report for the 52 weeks ended 25 March 2023; to re-elect Clive Whiley as a director of the Company; to re-elect Andrew Cook as a director of the Company; to re-elect Gillian Kent as a director of the Company; to re-elect Mark Newton-Jones as a director of the Company; to re-elect Brian Small as a director of the Company and to consider other business matters.Reported Earnings • Sep 24Full year 2023 earnings released: EPS: UK£0 (vs UK£0.021 in FY 2022)Full year 2023 results: EPS: UK£0 (down from UK£0.021 in FY 2022). Revenue: UK£73.1m (down 11% from FY 2022). Net loss: UK£100.0k (down 101% from profit in FY 2022). Revenue is forecast to stay flat during the next 3 years compared to a 5.9% growth forecast for the Specialty Retail industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 93% per year but the company’s share price has fallen by 21% per year, which means it is significantly lagging earnings.分析記事 • Aug 18We Like Mothercare's (LON:MTC) Returns And Here's How They're TrendingTo find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'd want to...New Risk • Jul 25New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of British stocks, typically moving 11% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (11% average weekly change). Earnings are forecast to decline by an average of 34% per year for the foreseeable future. Minor Risks High level of debt (883% net debt to equity). Market cap is less than US$100m (UK£34.2m market cap, or US$44.0m).分析記事 • Jun 11When Should You Buy Mothercare plc (LON:MTC)?Mothercare plc ( LON:MTC ), might not be a large cap stock, but it saw significant share price movement during recent...お知らせ • Jun 09+ 1 more updateMothercare plc Daniel Le Vesconte to Step Down from His Role as Director of the BoardMothercare plc announces that Daniel Le Vesconte has stepped down from his role as Chief Executive Officer ("CEO") and as a Director of the Board with immediate effect. Clive Whiley, the Company's Chairman and Andrew Cook, the CFO, will revert to leading the Operating Board, as was the case for the previous three years, until the process to find a replacement CEO is completed.分析記事 • Mar 13Mothercare (LON:MTC) Is Very Good At Capital AllocationWhat are the early trends we should look for to identify a stock that could multiply in value over the long term...Price Target Changed • Mar 12Price target decreased by 15% to UK£0.14Down from UK£0.17, the current price target is an average from 2 analysts. New target price is 63% above last closing price of UK£0.086. Stock is down 30% over the past year. The company is forecast to post earnings per share of UK£0.0015 for next year compared to UK£0.021 last year.Board Change • Mar 12Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Non Executive Director Brian Small was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Nov 30First half 2021 earnings released: UK£0.038 loss per shareThe company reported a poor first half result with weaker earnings, revenues and control over expenses. First half 2021 results: Revenue: UK£44.4m (down 56% from 1H 2020). Net loss: UK£14.1m (down 352% from profit in 1H 2020). Over the last 3 years on average, earnings per share has increased by 71% per year but the company’s share price has fallen by 44% per year, which means it is significantly lagging earnings.Reported Earnings • Sep 28Full year earnings released - UK£0.02 loss per shareOver the last 12 months the company has reported total losses of UK£7.20m, with losses narrowing by 67% from the prior year. Total revenue was UK£164.7m over the last 12 months, down 18% from the prior year.業績と収益の成長予測AIM:MTC - アナリストの将来予測と過去の財務データ ( )GBP Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数3/31/202934-20113/31/202832-3-1113/31/202730-31213/28/202622-500N/A12/28/2025261-1-1N/A9/27/2025306-3-2N/A6/27/2025346-3-2N/A3/29/2025396-3-1N/A12/29/202444302N/A9/28/202448035N/A6/28/202452235N/A3/30/202456335N/A12/30/202360213N/A9/23/202364102N/A6/23/202368113N/A3/25/202373024N/A12/25/202276446N/A9/24/202279958N/A6/24/2022811158N/A3/26/2022831258N/A12/26/2021834N/AN/AN/A9/25/202183-5-2-1N/A6/25/202184-13-2-2N/A3/27/202186-21-3-3N/A12/27/202096-24N/AN/AN/A10/10/2020107-2766N/A7/10/2020136-1823N/A3/28/2020165-8-11N/A12/28/201998-2N/A0N/A10/12/2019325N/A-1N/A7/12/2019116-8N/A0N/A3/30/2019200-21N/A1N/A10/6/2018511-99N/A8N/A7/6/2018546-96N/A5N/A3/24/2018581-93N/A1N/A12/24/2017657-41N/A4N/A10/7/2017659-7N/A8N/A7/7/20176631N/A12N/A3/25/20176678N/A15N/A12/25/20166745N/A12N/A10/8/20166802N/A9N/A7/8/20166814N/A15N/A3/26/20166826N/A22N/A12/26/2015687-4N/A16N/A10/10/2015691-15N/A10N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: MTC今後 3 年間、利益が出ない状態が続くと予測されています。収益対市場: MTC今後 3 年間、利益が出ない状態が続くと予測されています。高成長収益: MTC今後 3 年間、利益が出ない状態が続くと予測されています。収益対市場: MTCの収益 ( 11.8% ) UK市場 ( 3.9% ) よりも速いペースで成長すると予測されています。高い収益成長: MTCの収益 ( 11.8% ) 20%よりも低い成長が予測されています。一株当たり利益成長率予想将来の株主資本利益率将来のROE: MTCの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YRetail 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/08/21 00:02終値2026/08/21 00:00収益2026/03/28年間収益2026/03/28データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Mothercare plc 1 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。12 アナリスト機関Robert ChantryBerenbergSanjay VidyarthiCanaccord GenuityNigel ParsonCavendish9 その他のアナリストを表示
Major Estimate Revision • Dec 30Consensus revenue estimates decrease by 42%The consensus outlook for fiscal year 2026 has been updated. 2026 revenue forecast fell from UK£45.9m to UK£26.8m. EPS estimate unchanged from -UK£0.0025 per share at last update. Specialty Retail industry in the United Kingdom expected to see average net income growth of 37% next year. Consensus price target down from UK£0.098 to UK£0.072. Share price rose 15% to UK£0.025 over the past week.
Price Target Changed • Oct 18Price target decreased by 17% to UK£0.11Down from UK£0.13, the current price target is an average from 2 analysts. New target price is 115% above last closing price of UK£0.05. Stock is up 29% over the past year. The company is forecast to post earnings per share of UK£0.0049 next year compared to a net loss per share of UK£0.00018 last year.
Price Target Changed • Oct 18Price target decreased by 17% to UK£0.11Down from UK£0.13, the current price target is an average from 2 analysts. New target price is 115% above last closing price of UK£0.05. Stock is up 29% over the past year. The company is forecast to post earnings per share of UK£0.0049 next year compared to a net loss per share of UK£0.00018 last year.
Price Target Changed • Apr 19Price target increased by 15% to UK£0.15Up from UK£0.13, the current price target is provided by 1 analyst. New target price is 180% above last closing price of UK£0.053. Stock is down 39% over the past year. The company is forecast to post earnings per share of UK£0.005 next year compared to a net loss per share of UK£0.00018 last year.
Price Target Changed • Mar 12Price target decreased by 15% to UK£0.14Down from UK£0.17, the current price target is an average from 2 analysts. New target price is 63% above last closing price of UK£0.086. Stock is down 30% over the past year. The company is forecast to post earnings per share of UK£0.0015 for next year compared to UK£0.021 last year.
Reported Earnings • Aug 16Full year 2026 earnings released: UK£0.009 loss per share (vs UK£0.011 profit in FY 2025)Full year 2026 results: UK£0.009 loss per share (down from UK£0.011 profit in FY 2025). Revenue: UK£22.4m (down 42% from FY 2025). Net loss: UK£5.00m (down 181% from profit in FY 2025). Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 2.6% growth forecast for the Specialty Retail industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has fallen by 49% per year, which means it is significantly lagging earnings.
New Risk • Jul 12New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Share price has been highly volatile over the past 3 months (34% average weekly change). Negative equity (-UK£10m). Earnings are forecast to decline by an average of 72% per year for the foreseeable future. Market cap is less than US$10m (UK£3.95m market cap, or US$5.29m). Minor Risk Latest financial reports are more than 6 months old (reported September 2025 fiscal period end).
New Risk • Apr 14New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 91% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Share price has been highly volatile over the past 3 months (18% average weekly change). Negative equity (-UK£10m). Earnings are forecast to decline by an average of 91% per year for the foreseeable future. Market cap is less than US$10m (UK£6.29m market cap, or US$8.52m).
New Risk • Mar 23New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: UK£7.02m (US$9.43m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Share price has been highly volatile over the past 3 months (12% average weekly change). Negative equity (-UK£10m). Earnings are forecast to decline by an average of 95% per year for the foreseeable future. Market cap is less than US$10m (UK£7.02m market cap, or US$9.43m).
New Risk • Mar 01New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of British stocks, typically moving 11% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Share price has been highly volatile over the past 3 months (11% average weekly change). Negative equity (-UK£10m). Earnings are forecast to decline by an average of 95% per year for the foreseeable future. Minor Risk Market cap is less than US$100m (UK£11.0m market cap, or US$14.8m).
分析記事 • Jan 15Some Confidence Is Lacking In Mothercare plc's (LON:MTC) P/SIt's not a stretch to say that Mothercare plc's ( LON:MTC ) price-to-sales (or "P/S") ratio of 0.4x seems quite...
New Risk • Jan 14New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of British stocks, typically moving 11% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Share price has been highly volatile over the past 3 months (11% average weekly change). Negative equity (-UK£10m). Earnings are forecast to decline by an average of 85% per year for the foreseeable future. Minor Risk Market cap is less than US$100m (UK£11.3m market cap, or US$15.2m).
Major Estimate Revision • Dec 30Consensus revenue estimates decrease by 42%The consensus outlook for fiscal year 2026 has been updated. 2026 revenue forecast fell from UK£45.9m to UK£26.8m. EPS estimate unchanged from -UK£0.0025 per share at last update. Specialty Retail industry in the United Kingdom expected to see average net income growth of 37% next year. Consensus price target down from UK£0.098 to UK£0.072. Share price rose 15% to UK£0.025 over the past week.
Reported Earnings • Dec 25First half 2026 earnings released: UK£0.003 loss per share (vs UK£0.003 loss in 1H 2025)First half 2026 results: UK£0.003 loss per share (in line with 1H 2025). Revenue: UK£11.6m (down 45% from 1H 2025). Net loss: UK£1.70m (loss narrowed 5.6% from 1H 2025). Revenue is forecast to grow 1.1% p.a. on average during the next 3 years, compared to a 3.5% growth forecast for the Specialty Retail industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has fallen by 33% per year, which means it is significantly lagging earnings.
お知らせ • Sep 26Mothercare plc, Annual General Meeting, Nov 12, 2025Mothercare plc, Annual General Meeting, Nov 12, 2025. Location: westside 1, london road, hp3 9td, hemel hempstead United Kingdom
Reported Earnings • Sep 25Full year 2025 earnings released: EPS: UK£0.011 (vs UK£0.006 in FY 2024)Full year 2025 results: EPS: UK£0.011 (up from UK£0.006 in FY 2024). Revenue: UK£38.9m (down 31% from FY 2024). Net income: UK£6.20m (up 88% from FY 2024). Profit margin: 16% (up from 5.9% in FY 2024). The increase in margin was driven by lower expenses. Revenue is forecast to grow 9.2% p.a. on average during the next 3 years, compared to a 3.8% growth forecast for the Specialty Retail industry in the United Kingdom. Over the last 3 years on average, earnings per share has fallen by 57% per year but the company’s share price has only fallen by 31% per year, which means it has not declined as severely as earnings.
New Risk • Jun 25New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 16% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Negative equity (-UK£29m). Earnings are forecast to decline by an average of 16% per year for the foreseeable future. Minor Risks Latest financial reports are more than 6 months old (reported September 2024 fiscal period end). Share price has been volatile over the past 3 months (11% average weekly change). Market cap is less than US$100m (UK£16.2m market cap, or US$22.0m).
New Risk • Jun 20New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Negative equity (-UK£29m). Earnings are forecast to decline by an average of 16% per year for the foreseeable future. Minor Risks Latest financial reports are more than 6 months old (reported September 2024 fiscal period end). Share price has been volatile over the past 3 months (11% average weekly change). Market cap is less than US$100m (UK£14.7m market cap, or US$19.8m).
New Risk • May 12New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 16% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Negative equity (-UK£29m). Earnings are forecast to decline by an average of 16% per year for the foreseeable future. Minor Risk Market cap is less than US$100m (UK£12.6m market cap, or US$16.6m).
分析記事 • May 09Take Care Before Jumping Onto Mothercare plc (LON:MTC) Even Though It's 26% CheaperUnfortunately for some shareholders, the Mothercare plc ( LON:MTC ) share price has dived 26% in the last thirty days...
分析記事 • Mar 06Not Many Are Piling Into Mothercare plc (LON:MTC) Stock Yet As It Plummets 28%The Mothercare plc ( LON:MTC ) share price has fared very poorly over the last month, falling by a substantial 28%. For...
分析記事 • Jan 12Market Might Still Lack Some Conviction On Mothercare plc (LON:MTC) Even After 27% Share Price BoostMothercare plc ( LON:MTC ) shares have had a really impressive month, gaining 27% after a shaky period beforehand. Not...
Recent Insider Transactions • Dec 20Non-Executive Chairman recently bought UK£100k worth of stockOn the 18th of December, Clive Whiley bought around 4m shares on-market at roughly UK£0.025 per share. This transaction increased Clive's direct individual holding by 1x at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Clive's only on-market trade for the last 12 months.
お知らせ • Nov 22Mothercare plc Announces Resignation of Mark Newton from the BoardMothercare plc announced upon Clive Whiley’s appointment as Chairman, Mark Newton Jones agreed to return to the board as a non-executive director to lend his support to the Transformation Plan and subsequently the actions necessary to combat the impact of the pandemic and the Ukraine conflict on the business. Accordingly, following creation of the new India joint venture and coterminous refinancing, Mark had indicated his intention to stand down from the board at its AGM and has now resigned as a director.
お知らせ • Oct 22Mothercare plc, Annual General Meeting, Nov 19, 2024Mothercare plc, Annual General Meeting, Nov 19, 2024. Location: westside 1, london road, hp3 9td, hemel hempstead United Kingdom
分析記事 • Oct 20Mothercare plc's (LON:MTC) Shares Climb 49% But Its Business Is Yet to Catch UpMothercare plc ( LON:MTC ) shares have had a really impressive month, gaining 49% after a shaky period beforehand...
Reported Earnings • Oct 19First half 2024 earnings released: EPS: UK£0.003 (vs UK£0.001 in 1H 2023)First half 2024 results: EPS: UK£0.003 (up from UK£0.001 in 1H 2023). Revenue: UK£29.0m (down 25% from 1H 2023). Net income: UK£1.70m (up 325% from 1H 2023). Profit margin: 5.9% (up from 1.0% in 1H 2023). The increase in margin was driven by lower expenses. Revenue is expected to decline by 5.6% p.a. on average during the next 4 years, while revenues in the Specialty Retail industry in the United Kingdom are expected to grow by 5.4%.
Price Target Changed • Oct 18Price target decreased by 17% to UK£0.11Down from UK£0.13, the current price target is an average from 2 analysts. New target price is 115% above last closing price of UK£0.05. Stock is up 29% over the past year. The company is forecast to post earnings per share of UK£0.0049 next year compared to a net loss per share of UK£0.00018 last year.
Price Target Changed • Oct 18Price target decreased by 17% to UK£0.11Down from UK£0.13, the current price target is an average from 2 analysts. New target price is 115% above last closing price of UK£0.05. Stock is up 29% over the past year. The company is forecast to post earnings per share of UK£0.0049 next year compared to a net loss per share of UK£0.00018 last year.
New Risk • Sep 21New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of British stocks, typically moving 9.7% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.9x net interest cover). Share price has been highly volatile over the past 3 months (9.7% average weekly change). Negative equity (-UK£13m). High level of non-cash earnings (23% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported September 2023 fiscal period end). Profit margins are more than 30% lower than last year (1.9% net profit margin). Market cap is less than US$100m (UK£18.9m market cap, or US$25.2m).
分析記事 • Jul 04Is Mothercare plc (LON:MTC) Potentially Undervalued?Mothercare plc ( LON:MTC ), might not be a large cap stock, but it saw a decent share price growth of 13% on the AIM...
New Risk • Jun 11New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.9x net interest cover). Negative equity (-UK£13m). High level of non-cash earnings (23% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported September 2023 fiscal period end). Share price has been volatile over the past 3 months (10% average weekly change). Profit margins are more than 30% lower than last year (1.9% net profit margin). Market cap is less than US$100m (UK£26.2m market cap, or US$33.4m).
Price Target Changed • Apr 19Price target increased by 15% to UK£0.15Up from UK£0.13, the current price target is provided by 1 analyst. New target price is 180% above last closing price of UK£0.053. Stock is down 39% over the past year. The company is forecast to post earnings per share of UK£0.005 next year compared to a net loss per share of UK£0.00018 last year.
分析記事 • Apr 18Mothercare plc (LON:MTC) Shares May Have Slumped 25% But Getting In Cheap Is Still UnlikelyMothercare plc ( LON:MTC ) shareholders that were waiting for something to happen have been dealt a blow with a 25...
分析記事 • Jan 03Is Now The Time To Look At Buying Mothercare plc (LON:MTC)?Mothercare plc ( LON:MTC ), is not the largest company out there, but it led the AIM gainers with a relatively large...
Reported Earnings • Nov 28First half 2024 earnings released: EPS: UK£0.003 (vs UK£0.001 in 1H 2023)First half 2024 results: EPS: UK£0.003 (up from UK£0.001 in 1H 2023). Revenue: UK£29.0m (down 25% from 1H 2023). Net income: UK£1.70m (up 325% from 1H 2023). Profit margin: 5.9% (up from 1.0% in 1H 2023). The increase in margin was driven by lower expenses. Revenue is forecast to grow 2.2% p.a. on average during the next 3 years, compared to a 5.5% growth forecast for the Specialty Retail industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 110% per year but the company’s share price has fallen by 23% per year, which means it is significantly lagging earnings.
New Risk • Nov 26New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 2.3x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.3x net interest cover). Negative equity (-UK£13m). High level of non-cash earnings (23% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (10.0% average weekly change). Profit margins are more than 30% lower than last year (1.9% net profit margin). Market cap is less than US$100m (UK£29.9m market cap, or US$37.7m).
分析記事 • Nov 04Mothercare plc (LON:MTC) Investors Are Less Pessimistic Than ExpectedWith a median price-to-sales (or "P/S") ratio of close to 0.3x in the Specialty Retail industry in the United Kingdom...
お知らせ • Sep 27Mothercare plc, Annual General Meeting, Oct 23, 2023Mothercare plc, Annual General Meeting, Oct 23, 2023, at 10:00 Coordinated Universal Time. Location: Westside 1, London Road Hemel Hemsptead United Kingdom Agenda: To receive the Company's annual accounts, together with the directors' report, the strategic report, the directors' remuneration report and the auditors' report for the 52 weeks ended 25 March 2023; to approve the directors' remuneration report for the 52 weeks ended 25 March 2023; to re-elect Clive Whiley as a director of the Company; to re-elect Andrew Cook as a director of the Company; to re-elect Gillian Kent as a director of the Company; to re-elect Mark Newton-Jones as a director of the Company; to re-elect Brian Small as a director of the Company and to consider other business matters.
Reported Earnings • Sep 24Full year 2023 earnings released: EPS: UK£0 (vs UK£0.021 in FY 2022)Full year 2023 results: EPS: UK£0 (down from UK£0.021 in FY 2022). Revenue: UK£73.1m (down 11% from FY 2022). Net loss: UK£100.0k (down 101% from profit in FY 2022). Revenue is forecast to stay flat during the next 3 years compared to a 5.9% growth forecast for the Specialty Retail industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 93% per year but the company’s share price has fallen by 21% per year, which means it is significantly lagging earnings.
分析記事 • Aug 18We Like Mothercare's (LON:MTC) Returns And Here's How They're TrendingTo find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'd want to...
New Risk • Jul 25New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of British stocks, typically moving 11% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (11% average weekly change). Earnings are forecast to decline by an average of 34% per year for the foreseeable future. Minor Risks High level of debt (883% net debt to equity). Market cap is less than US$100m (UK£34.2m market cap, or US$44.0m).
分析記事 • Jun 11When Should You Buy Mothercare plc (LON:MTC)?Mothercare plc ( LON:MTC ), might not be a large cap stock, but it saw significant share price movement during recent...
お知らせ • Jun 09+ 1 more updateMothercare plc Daniel Le Vesconte to Step Down from His Role as Director of the BoardMothercare plc announces that Daniel Le Vesconte has stepped down from his role as Chief Executive Officer ("CEO") and as a Director of the Board with immediate effect. Clive Whiley, the Company's Chairman and Andrew Cook, the CFO, will revert to leading the Operating Board, as was the case for the previous three years, until the process to find a replacement CEO is completed.
分析記事 • Mar 13Mothercare (LON:MTC) Is Very Good At Capital AllocationWhat are the early trends we should look for to identify a stock that could multiply in value over the long term...
Price Target Changed • Mar 12Price target decreased by 15% to UK£0.14Down from UK£0.17, the current price target is an average from 2 analysts. New target price is 63% above last closing price of UK£0.086. Stock is down 30% over the past year. The company is forecast to post earnings per share of UK£0.0015 for next year compared to UK£0.021 last year.
Board Change • Mar 12Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Non Executive Director Brian Small was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Nov 30First half 2021 earnings released: UK£0.038 loss per shareThe company reported a poor first half result with weaker earnings, revenues and control over expenses. First half 2021 results: Revenue: UK£44.4m (down 56% from 1H 2020). Net loss: UK£14.1m (down 352% from profit in 1H 2020). Over the last 3 years on average, earnings per share has increased by 71% per year but the company’s share price has fallen by 44% per year, which means it is significantly lagging earnings.
Reported Earnings • Sep 28Full year earnings released - UK£0.02 loss per shareOver the last 12 months the company has reported total losses of UK£7.20m, with losses narrowing by 67% from the prior year. Total revenue was UK£164.7m over the last 12 months, down 18% from the prior year.